Salvia BioElectronics Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 49

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 12

Salvia BioElectronics General Information

Description

Developer of bioelectronic technology designed to assist in the treatment of chronic neurological disease. The company's technology includes smart devices that use mild electrical impulses to influence nerve activity that restores health for people suffering from chronic migraine, enabling patients to access a neurostimulation alternative for drug-refractory migraine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • High Tech Campus 37
  • 5656 AE Eindhoven
  • Netherlands
Primary Industry
Therapeutic Devices
Vertical(s)
Corporate Office
  • High Tech Campus 37
  • 5656 AE Eindhoven
  • Netherlands

Salvia BioElectronics Timeline

2022202320242025
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Salvia BioElectronics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 29-May-2024 Completed Clinical Trials - General
6. Grant 08-Nov-2023 Completed Clinical Trials - General
5. Early Stage VC (Series A) 22-Sep-2020 Completed Startup
4. Seed Round 31-Jan-2019 Completed Startup
3. Grant 01-Jun-2018 Completed Startup
2. Seed Round 22-May-2018 $1.55M $1.55M Completed Startup
1. Accelerator/Incubator Completed Startup
To view Salvia BioElectronics’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Salvia BioElectronics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of bioelectronic technology designed to assist in the treatment of chronic neurological disease. The company's
Therapeutic Devices
Eindhoven, Netherlands
49 As of 2025

Artarmon, Australia
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Salvia BioElectronics Competitors (14)

One of Salvia BioElectronics’s 14 competitors is Saluda Medical, a Private Equity-Backed company based in Artarmon, Australia.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Saluda Medical Private Equity-Backed Artarmon, Australia
CVRx Formerly VC-backed Minneapolis, MN
Mainstay Medical Venture Capital-Backed San Diego, CA
Theranica Venture Capital-Backed Netanya, Israel
Curonix Private Equity-Backed Pompano Beach, FL
You’re viewing 5 of 14 competitors. Get the full list »

Salvia BioElectronics Patents

Salvia BioElectronics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4392123-A1 Implantable stimulator with an electrode array, conformable substrate, and mechanical strain relief Pending 25-Aug-2021
CA-3226804-A1 Implantable stimulator with an electrode array, conformable substrate, and mechanical strain relief Pending 25-Aug-2021
AU-2022334998-A1 Implantable stimulator with an electrode array, conformable substrate, and mechanical strain relief Pending 25-Aug-2021
JP-2024530976-A Implantable stimulator with electrode array, compliant substrate, and mechanical strain relief - patent application Pending 25-Aug-2021
US-20230001185-A1 System and method for self-programming stimulation settings Pending 30-Jun-2021 A61N1/0526
To view Salvia BioElectronics’s complete patent history, request access »

Salvia BioElectronics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Salvia BioElectronics Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
MedTech Innovator Accelerator/Incubator
European Innovation Council Fund Venture Capital Minority
Dolby Family Ventures Venture Capital Minority
Inkef Venture Capital Minority
Panakes Partners Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Salvia BioElectronics FAQs

  • When was Salvia BioElectronics founded?

    Salvia BioElectronics was founded in 2017.

  • Where is Salvia BioElectronics headquartered?

    Salvia BioElectronics is headquartered in Eindhoven, Netherlands.

  • What is the size of Salvia BioElectronics?

    Salvia BioElectronics has 49 total employees.

  • What industry is Salvia BioElectronics in?

    Salvia BioElectronics’s primary industry is Therapeutic Devices.

  • Is Salvia BioElectronics a private or public company?

    Salvia BioElectronics is a Private company.

  • What is Salvia BioElectronics’s current revenue?

    The current revenue for Salvia BioElectronics is .

  • How much funding has Salvia BioElectronics raised over time?

    Salvia BioElectronics has raised $34.4M.

  • Who are Salvia BioElectronics’s investors?

    MedTech Innovator, European Innovation Council Fund, Dolby Family Ventures, Inkef, and Panakes Partners are 5 of 12 investors who have invested in Salvia BioElectronics.

  • Who are Salvia BioElectronics’s competitors?

    Saluda Medical, CVRx, Mainstay Medical, Theranica, and Curonix are some of the 14 competitors of Salvia BioElectronics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »